WHO prequalifies Bavarian Nordic’s vaccine against Mpox ...Middle East

News room odisha - News
WHO prequalifies Bavarian Nordic’s vaccine against Mpox
New Delhi: Amid the global outbreak of Mpox, the World Health Organization (WHO) on Thursday announced prequalifying Bavarian Nordic’s vaccine — a first against the deadly monkeypox virus (MPXV). Modified Vaccinia Ankara-Bavarian Nordic or MVA-BN is indicated for active immunisation against smallpox, Mpox, and related orthopoxvirus infections and disease in all adults 18 years of age and older. The vaccine can be administered as a 2-dose injection given 4 weeks apart. “Available data shows that a single-dose MVA-BN vaccine given before exposure has an estimated 76 per cent effectiveness in protecting people against Mpox, with the 2-dose schedule achieving an estimated 82 per cent effectiven

Hence then, the article about who prequalifies bavarian nordic s vaccine against mpox was published today ( ) and is available on News room odisha ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( WHO prequalifies Bavarian Nordic’s vaccine against Mpox )

Apple Storegoogle play

Last updated :

Also on site :